![Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples - ScienceDirect Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0045653509011722-gr1.jpg)
Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples - ScienceDirect
![Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_021_FP1215_T2.jpg.jpg)
Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner
![Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_024_FP1215_T7.jpg.jpg)
Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner
![Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement - U.S. Preventive Services Task Force - American Family Physician Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement - U.S. Preventive Services Task Force - American Family Physician](https://www.aafp.org/afp/2017/0115/hi-res/afp20170115od1-t2.gif)
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement - U.S. Preventive Services Task Force - American Family Physician
![References in Rosuvastatin: A High-Potency HMG-CoA Reductase Inhibitor - Journal of the American Pharmacists Association References in Rosuvastatin: A High-Potency HMG-CoA Reductase Inhibitor - Journal of the American Pharmacists Association](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2042827553/2055610270/gr1.gif)
References in Rosuvastatin: A High-Potency HMG-CoA Reductase Inhibitor - Journal of the American Pharmacists Association
![Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients - Journal of Clinical Lipidology Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients - Journal of Clinical Lipidology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1065626/7811139/gr1.jpg)
Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients - Journal of Clinical Lipidology
![Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction](https://www.spandidos-publications.com/article_images/etm/14/5/etm-14-05-4942-g01.jpg)
Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction
Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India
![Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients](https://static-01.hindawi.com/articles/isrn/volume-2013/146579/figures/146579.fig.001.jpg)
Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
Table 1, Statin Dosing and ACC/AHA Classification of Intensity - Statin Use for the Prevention of Cardiovascular Disease in Adults - NCBI Bookshelf
![Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association | Circulation Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/759b64df-e353-497e-b128-f40991968c63/e468fig01.jpeg)